.Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC15_Reproterol.Reproterol .Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC15_Reproterol.Reproterol| name: | Reproterol |
| ATC code: | R03AC15 | route: | intravenous |
| n-compartments | 1 |
Reproterol is a short-acting β2-adrenoceptor agonist used for the treatment of asthma and other pulmonary diseases. It is employed as a bronchodilator and is most commonly administered by inhalation or intravenously in acute asthma attacks. Its use is currently approved in some countries but not widely available in all regions.
No published human pharmacokinetic studies available for reproterol; all values below are estimates extrapolated from general knowledge of similar short-acting β2-agonists and limited product information for typical adult patients.